Cardiovascular Biology
CRISPR Applications in Cardiovascular Biology
Human cardiac development and its regulatory mechanisms.
Li et al., Signal Transduct Target Ther, 2024
Decoding Cardiac Development, Disease Mechanisms, and Therapeutic Targets Through Precision Gene Editing
Cardiovascular diseases remain one of the leading causes of mortality worldwide, driven by complex genetic networks involved in cardiac development, myocardial function, metabolism, and disease progression.
From congenital heart defects during embryonic development to inherited cardiomyopathies and metabolic cardiovascular disorders, understanding the functional role of disease-associated genes is essential for identifying new biological mechanisms and therapeutic opportunities.
Traditional approaches often reveal correlations between genetic variants and cardiovascular phenotypes but are limited in determining causal relationships. CRISPR-based genome editing technologies enable researchers to precisely manipulate genes in cellular and animal models, providing powerful tools for functional validation.
CRISPR technology is transforming cardiovascular research by enabling:
EDITGENE provides integrated CRISPR solutions for cardiovascular research, supporting projects from genome engineering design to disease model development and functional validation.
Cardiac development is a highly coordinated process regulated by complex genetic networks. During embryonic development, signaling pathways, transcription factors, and epigenetic regulators collectively control mesoderm specification, cardiac lineage commitment, and cardiomyocyte maturation.
Human pluripotent stem cell (hPSC)-derived cardiomyocyte differentiation systems provide powerful platforms for studying human cardiac development. Combined with CRISPR technology, these models enable systematic investigation of gene function during cardiac lineage specification.
CRISPR screening enables large-scale identification of genes involved in:
By integrating CRISPR libraries with reporter-based differentiation systems, researchers can discover novel regulators of cardiac development.
Inherited cardiovascular diseases, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and genetic arrhythmias, are frequently caused by mutations affecting sarcomere proteins, ion channels, and cardiac regulatory genes.
CRISPR technology enables researchers to introduce, correct, or precisely modify disease-associated variants to generate clinically relevant models.
HCM is one of the most common inherited cardiac disorders, frequently associated with mutations in genes such as MYBPC3 and MYH7.
CRISPR-based approaches enable:
Abnormal lipid metabolism is a major contributor to cardiovascular disease, including atherosclerosis and coronary artery disease.
CRISPR technology enables systematic investigation of genes involved in lipid synthesis, transport, and regulation, supporting discovery of new cardiovascular targets.
PCSK9 plays a central role in LDL receptor regulation and cholesterol metabolism.
CRISPR approaches enable researchers to study:
The limited regenerative capacity of adult cardiomyocytes remains a major challenge in cardiovascular biology.
CRISPR technology provides new opportunities to investigate genes regulating cardiomyocyte proliferation, stem cell differentiation, and tissue repair.
From fundamental discovery to translational research, EDITGENE supports the complete cardiovascular research workflow:
| Research Area | Key Scientific Question | CRISPR Strategy | EDITGENE Support |
| Cardiomyocyte Differentiation | Which genes control cardiac cell fate? | CRISPR screening, KO, CRISPRi/a | Screening libraries, stem cell models |
| Genetic Cardiomyopathy | How do mutations drive cardiac disease? | KI, KO, base editing | iPSC disease models, mutation correction |
| Lipid Metabolism | Which genes regulate cardiovascular risk? | Gene knockout, activation, screening | Metabolic models, functional analysis |
| Cardiac Regeneration | How can cardiac repair pathways be enhanced? | Stem cell genome engineering | Stem cell engineering and validation |
EDITGENE provides reliable CRISPR solutions supporting cardiovascular biology research from concept to validated models.
Advanced Genome Editing Platforms
Proprietary sgRNA Design Algorithms
Extensive Project Experience
Comprehensive Editing Modes
iPSC and Disease Model Development
Rapid Project Execution
Flexible Customization
Integrated Workflow
From uncovering cardiac development mechanisms to modeling inherited cardiomyopathies, identifying metabolic targets, and exploring cardiac regeneration pathways, EDITGENE empowers researchers with reliable CRISPR technologies for next-generation cardiovascular research.
